Anavex Life Sciences recently announced that its clinical trial application for ANAVEX 2-73, the company’s lead compound for Alzheimer’s disease, has been approved by the German regulatory health authority.
Year: 2011
A new non-surgical, tissue-preserving therapeutic procedure is being developed to more effectively remove HPV infection and treat precursors of cervical cancer.
Neo Matrix is a medical devices company that has developed a novel diagnostic test to…
RealBio’s technology allows cells grown in a laboratory setting to develop as they would in a normal human body.
Wednesday, March 23 – Thursday, March 24, 2011 Washington, DC Metro Area The Liaison Capitol…
A new market research report on the In Vitro Diagnostic market is now available in the reportlinker.com catalogue.
Women should be aware that they have several options for colon cancer screening, and not only the often-dreaded colonoscopy, according to a new report from the American College of Obstetricians and Gynecologists.
Cermed Corporation is a medical devices company that has developed an apparatus for advanced diagnostic…